New Data Released by Theratechnologies Demonstrate Positive Impact of Tesamorelin in Patients with Liver Fibrosis

Jun 14, 2019
PDF Version
Supporting Materials:
Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce additional data from the recently completed study funded by the National Institutes of Health, led by Dr. Steve Grinspoon, and conducted at the Massachusetts General Hospital and Harvard Medical School and the National Institutes of Health.